November 26, 2014 9:44 PM ET

Pharmaceuticals

Company Overview of Elixir Pharmaceuticals, Inc.

Executive Profile

Lawrence Blonde M.D.

Member of the Diabetes Advisory Board, Elixir Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 1 different industries.

See Board Relationships
----

Background

Lawrence Blonde, M.D. serves as Director of the Ochsner Health System Diabetes Clinical Research Unit in New Orleans. Dr. Blonde has been Member of the Diabetes Advisory Board of Elixir Pharmaceuticals, Inc., since April 2008. He is also Chair of the Steering Committee of the National Diabetes Education Program (NDEP), a partnership of the National Institutes of Health (NIH), the Centers for Disease Control and Prevention and more than 200 public and private organizations. ...

Corporate Headquarters

300 Putnam Avenue
Cambridge, Massachusetts 02139

United States

Phone: 617-995-7000
Fax: 617-995-7050

Board Members Memberships

There is no Board Members Memberships data available.

Education

MD
Albany Medical College

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Elixir Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.